AOD 9604 is a new peptide therapy with all the medical weight loss benefits and none of the side effects
The 2026 Sports Medicine and JAAOS Global Research and Reviews papers (PMID 41966639, PMID 41490200) place multiple compounds including this one into the wider research context of unapproved compounds under active investigation, with attention to both the mechanism findings and the regulatory framing that researchers consulting these reviews should weigh equally
Oral B12 supplements are absorbed at roughly 1 to 5% in healthy adults, and even less in people with low intrinsic factor, atrophic gastritis, or gut absorption issues
Treatment results were immediate
By promoting efficient fat metabolism and reducing the formation of new fat deposits, AOD9604 can help mitigate risks associated with obesity-related conditions, such as diabetes, hypertension, and cardiovascular diseases